Alpa Laboratories Limited (NSEI: ALPA)
Health Care · Pharmaceuticals · IN
Rs59.26
+0.27% today · -33.2% 1Y
Alpa Laboratories Limited (NSEI: ALPA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $12.95M and employs 457 people.
Over the last twelve months the share price has lost 33.2%, trading between 46.10 and 93.85.
Tweenvest scores Alpa Laboratories Limited across four factors: quality 77/100, value 67/100, growth 34/100. Its strongest factor is quality.
ALPA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $12.95M
- Revenue (TTM)
- $11.70M
- P/E
- 28.08
- EPS
- 2.11
- Dividend yield
- —
- Beta (5Y)
- 0.91
- 52-week high
- Rs93.85
- 52-week low
- Rs46.10
- Avg volume (3M)
- —
- Shares outstanding
- 21.04M
- Employees
- 457
- Next earnings
- —
About Alpa Laboratories Limited
Established in Indore, India in 1967, Alpa Laboratories Limited focuses on the manufacturing, marketing, and distribution of finished pharmaceutical products, both domestically within India and for export. The company offers a wide array of human-grade medications, encompassing ethical, generic, and over-the-counter varieties, available in diverse forms such as injections, tablets, capsules, eye and ear drops, ointments, creams, and gels. Furthermore, it supplies veterinary pharmaceuticals, including boluses, injections, and intra-mammary infusions. Its extensive product range addresses numerous therapeutic categories, including anti-infectives (covering antibacterials, antibiotics, antifungals, antiprotozoals, and antivirals), pain relievers, anti-inflammatory drugs, cold and cough remedies, cardiovascular treatments, anti-diabetic agents, nutritional supplements, psychotropic medicines, and specialized preparations for skin, ear, and eye care. Alpa Laboratories distributes its goods through a robust network comprising distributors, retail pharmacies, and hospitals. The company also extends its reach internationally, exporting its products to various regions across South and Central America, Africa, Asia, and the CIS countries.
- ISIN
- INE385I01010
- Founded
- 1967
- Listed since
- Aug 6, 2007
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Ayr Wellness Inc.CNSX: AYR.A | $13.21M | CA$— | — |
| PT Phapros TbkIDX: PEHA | $13.14M | Rp280.00 | -2.78% |
| Lobe Sciences Ltd.CNSX: LOBE | $13.10M | CA$0.06 | -26.67% |
| Anebulo Pharmaceuticals, Inc.OTCPK: ANEB | $13.05M | $0.32 | -1.54% |
| FLUENT Corp.CNSX: FNT.U | $12.76M | $0.02 | -20.00% |
| Liven Pharma LimitedKASE: LIVEN | $12.71M | PKRs31.14 | -1.14% |
| Light AI Inc.DB: 0HC | $12.47M | €0.09 | +12.21% |
| Biogened S.A.WSE: BGD | $12.44M | zł18.90 | -4.06% |
Figures last refreshed Oct 4, 2026.